Examining Changes in Microbiota Over the Course of PTSD Treatment
NCT ID: NCT04109196
Last Updated: 2023-06-22
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
24 participants
INTERVENTIONAL
2019-10-01
2021-04-09
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of Evidence-Based PTSD Treatment Via Prebiotic Supplementation
NCT05424146
Exploring Mechanisms of Massed Cognitive Processing Therapy
NCT05265039
Evaluating Evidenced Based Options for PTSD Treatment
NCT06733376
Mindfulness-Based Stress Reduction and the Microbiome
NCT01619384
Cognitive Behavioral Therapy for Post-Traumatic Stress Disorder in Individuals With Severe Mental Illness
NCT00078741
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Study staff will administer brief computerized assessments (e.g. Stroop task), a full self-report assessment battery, and two internet-based dietary assessments to all participants. Study staff will also collect fecal- and oral-derived microbiota and salivary cytokine samples from individuals who opt in to this aspect of the study.
Study Treatment - Intensive Week-Long Cognitive Processing Therapy (CPT):
The individuals in this study will undergo a course of 1-week-long Cognitive Processing Therapy (CPT-5). CPT-5 will be delivered twice per day over the course of five business days. Each 50 minute session will closely follow the CPT protocol and will be conducted by either Dr. Held, other doctoral-level psychologists, postdoctoral fellows, or other Master's level (or higher) clinicians who have received the official two-day CPT training and who are not involved in study assessments. CPT worksheets and homework assignments may be collected and copied for research purposes. Changes in PTSD severity and other relevant symptoms will be assessed before, during, and after the course of CPT using well-validated clinician-administered, self-report, and computerized assessments. Fecal- and oral-derived microbiota as well as salivary cytokines will also be assessed at various pre-treatment, post-treatment, and follow-up time points to determine whether the microbiome and cytokine levels change over the course of CPT. Participants in this study will have the option to opt out of providing these biological samples and still receive CPT-5.
Semi-Structured Interview:
Regardless of whether they completed the course of CPT, participants in the study may be asked to participate in one 20-40 minute semi-structured interview. The interviewer, who is a member of the research team and not the respective participant's study therapist, will ask general questions about the participant's experiences of CPT-5 and gather information about the participant's perceptions of the tolerability, acceptability, and feasibility of the intervention.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intensive 5-day Cognitive Processing Therapy for PTSD
Participants who are eligible for and enrolled in the study will receive a 5-day CPT treatment for PTSD. All participants will be asked to complete clinician-rated and self-report assessments at multiple time points during the study. Participants will also be asked to provide fecal and saliva samples as part of the study, however, they may opt out of biological sample collection.
Cognitive Processing Therapy
Cognitive Processing Therapy is an evidence-based treatment for PTSD that will be delivered intensively twice per day over the course of five days.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cognitive Processing Therapy
Cognitive Processing Therapy is an evidence-based treatment for PTSD that will be delivered intensively twice per day over the course of five days.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Are 18 years or older
2. Are fluent in English
3. Have experienced a Criterion A traumatic event during their lifetime
4. Have a PTSD diagnosis verified by the Clinician Administered PTSD Scale for DSM-5
5. Are interested in receiving evidence-based treatment (CPT) for PTSD and able to attend 10 therapy sessions over the course of one week (5 days)
6. Are willing and interested to complete self-report measures and clinician-rated assessments at multiple time points over the course of the study
Exclusion Criteria
1. The traumatic event occurred in the past month
2. They are currently suicidal or homicidal, as indicated by a positive screen on the C-SSRS Question 4 or Question 5 at intake.
3. They have a history of psychosis or mania
4. They have not been on a stable dose of medication for at least one month
5. They have dietary patterns not representative of normal populations (e.g., vegetarian, vegan, gluten-free)
6. They made changes to the diet in the past month or are planning to make changes over the course of therapy
7. They have completed an evidence-based PTSD treatment in the past 3 months or are currently receiving an evidence-based PTSD treatment
8. They have mental retardation or significant cognitive impairment that would prevent them from engaging in CPT
9. They have a serious or unstable medical illness or instability for which hospitalization may be likely within the next year
10. They have an active substance use disorder (within the past 3 months)
11. They are involved with current legal actions related to the traumatic event that is anticipated to be targeted during treatment
12. They have a history or presence of an eating disorder
13. They are currently taking or have taken an antibiotic in the past 30 days
14. They are currently taking a corticosteroid
15. They have had part of the digestive tract removed or altered
16. They have had any surgery or procedure within the past 30 days that has required fasting for more than 12 hours or bowel preparation beforehand
17. They are unwilling to provide fecal and saliva samples (applies to trauma-exposed control condition only)
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institutes of Health (NIH)
NIH
University of Chicago
OTHER
National Center for Advancing Translational Sciences (NCATS)
NIH
Rush University Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Philip Held
Research Director
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rush University Medical Center
Chicago, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
18011005
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.